新迅达 reported revenue of ¥0.08B for the period ended 2026-06-30, -7.4% year on year. Net income was ¥-0.06B, a -77.2% net margin on a 26.3% gross margin. The largest revenue line is 电商直销业务 at 92% of the total. Free cash flow for the period was ¥-0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.08B | -7.4% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.07B | — |
| Net income | ¥-0.06B | — |
| Gross margin | 26.3% | Net margin -77.2% |
| Revenue Q/Q | -58.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 电商直销业务 | ¥0.07B | 91.7% |
| 锂矿产品 | ¥0.01B | 8.2% |
| 游戏运营业务 | ¥0.00B | 0.1% |
| 直播电商业务 | ¥0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 73.7% |
| SG&A | ¥0.05B | 59.3% |
| Tax & other | ¥-0.01B | -7.7% |
| Item | Amount |
|---|---|
| Total assets | ¥0.87B |
| Total liabilities | ¥0.12B |
| Shareholders' equity | ¥0.75B |
| Equity / assets | 86.7% |
| Operating cash flow | ¥-0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.02B |
| Cash conversion (OCF / net income) | 24% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新光药业 ・ 科大国创 ・ 爱司凯 ・ 世名科技 ・ 辰安科技 ・ 博思软件 ・ ST应急 ・ 幸福蓝海 ・ 健帆生物 ・ 领湃科技 ・ 优博讯 ・ 今天国际
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies